KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Retained Earnings (2017 - 2025)

Historic Retained Earnings for Moderna (MRNA) over the last 9 years, with Q3 2025 value amounting to $8.0 billion.

  • Moderna's Retained Earnings fell 2790.86% to $8.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 billion, marking a year-over-year decrease of 2790.86%. This contributed to the annual value of $10.0 billion for FY2024, which is 2617.23% down from last year.
  • Per Moderna's latest filing, its Retained Earnings stood at $8.0 billion for Q3 2025, which was down 2790.86% from $8.2 billion recorded in Q2 2025.
  • In the past 5 years, Moderna's Retained Earnings registered a high of $18.4 billion during Q1 2023, and its lowest value of -$1.0 billion during Q1 2021.
  • Over the past 5 years, Moderna's median Retained Earnings value was $11.2 billion (recorded in 2024), while the average stood at $11.2 billion.
  • Its Retained Earnings has fluctuated over the past 5 years, first surged by 143088.95% in 2022, then tumbled by 3447.32% in 2024.
  • Moderna's Retained Earnings (Quarter) stood at $10.0 billion in 2021, then surged by 83.97% to $18.3 billion in 2022, then decreased by 25.73% to $13.6 billion in 2023, then fell by 26.17% to $10.0 billion in 2024, then decreased by 19.87% to $8.0 billion in 2025.
  • Its Retained Earnings stands at $8.0 billion for Q3 2025, versus $8.2 billion for Q2 2025 and $9.1 billion for Q1 2025.